Thrombocytopenia: proposed mechanisms and treatment in human immunodeficiency virus infection
Glassman, A.B.
Annals of Clinical and Laboratory Science 19(5): 319-322
1989
ISSN/ISBN: 0091-7370 PMID: 2679349 Document Number: 335476
Thrombocytopenia (TC) is noted in three to nine percent of patients who are seropositive for human immunodeficiency virus (HIV). Causes of this may be immune, infectious, platelet destruction, or underproduction. Thrombocytopenia associated with HIV will be seen with increasing frequency. Corticosteroids and splenectomy are the usual therapeutic approaches. Intravenous gammaglobulin and antiviral agents may be indicated and useful in some patients.
Document emailed within 1 workday
Related Documents
Kline, M.W.; Lewis, D.E.; Hollinger, F.B.; Reuben, J.M.; Hanson, L.C.; Kozinetz, C.A.; Dimitrov, D.H.; Rosenblatt, H.M.; Shearer, W.T. 1994: A comparative study of human immunodeficiency virus culture, polymerase chain reaction and anti-human immunodeficiency virus immunoglobulin A antibody detection in the diagnosis during early infancy of vertically acquired human immunodeficiency virus infection Pediatric Infectious Disease Journal 13(2): 90-94Muñiz-Díaz, E.; Domingo, P.; López, M.; Pujol-Moix, N.; Fuster, M.; Madoz, P. 1993: Thrombocytopenia associated with human immunodeficiency virus infection. Immunologic study of 60 patients addicted to parenteral drugs Medicina Clinica 101(20): 761-765
Kidangazhiayathmana, A. 2011: Is Kerala remaining low prevalent in human immunodeficiency virus by accident? a study of risk factors in acquiring human immunodeficiency virus infection in patients attending Anti-retroviral treatment clinic Indian Journal of Dermatology Venereology and Leprology 77(6): 729
Borkowsky, W.; Krasinski, K. 1992: Perinatal human immunodeficiency virus infection: ruminations on mechanisms of transmission and methods of intervention Pediatrics 90(1 Part 2): 133-136
Anonymous 1988: 1988 agent summary statement for human immunodeficiency virus and report on laboratory-acquired infection with human immunodeficiency virus Morbidity and Mortality Weekly Report 37(S-4): 22
Lin, W.-C.; Lin, H.-H.; Lee, S.S.-J.; Sy, C.-L.; Wu, K.-S.; Chen, J.-K.; Tsai, H.-C.; Chen, Y.-S. 2016: Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country Journal of Microbiology Immunology and Infection 49(5): 729-736
Koyanagi, A.; Humphrey, J.H.; Ntozini, R.; Nathoo, K.; Moulton, L.H.; Iliff, P.; Mutasa, K.; Ruff, A.; Ward, B.; Chidawanyika, H.; Hargrove, J.; Mahomva, A.I.; Majo, F.; Malaba, L.C.; Mbizvo, M.T.; Mzengeza, F.; Ndhlovu, M.; Piwoz, E.; Propper, L.; Rambanepasi, P.; Ruff, A.J.; Tavengwa, N.; Zijenah, L.S.; Zunguza, C.D.; Zvandasara, P. 2011: Morbidity among human immunodeficiency virus-exposed but uninfected, human immunodeficiency virus-infected, and human immunodeficiency virus-unexposed infants in Zimbabwe before availability of highly active antiretroviral therapy Pediatric Infectious Disease Journal 30(1): 45-51
Ellaurie, M.; Burns, E.R.; Bernstein, L.J.; Shah, K.; Rubinstein, A. 1988: Thrombocytopenia and human immunodeficiency virus in children Pediatrics 82(6): 905-908
Segat, L.; Crovella, S. 2012: HLA-G 14bp del/ins genetic variation: association with susceptibility to human immunodeficiency virus-1 vertical transmission but not with human immunodeficiency virus-1 infection through horizontal transmission Tissue Antigens 80(1): 12-13
Wen, Y.; Guan, J.; Wu, Z.; Li, L.; Rotheram-Borus, M.Jane.; Lin, C.; Detels, R. 2009: Pharmacy workers' sexually transmitted diseases/human immunodeficiency virus knowledge in Fuzhou, China: implications for human immunodeficiency virus testing, treatment, and prevention strategies Sexually Transmitted Diseases 36(4): 221-226
Blum, L.; Bachmeyer, C. 1997: Antiretroviral treatment in human immunodeficiency virus infection Annales de Dermatologie et de Venereologie 124(9): 641-654
Henry, D.H.; Beall, G.N.; Benson, C.A.; Carey, J.; Cone, L.A.; Eron, L.J.; Fiala, M.; Fischl, M.A.; Gabin, S.J.; Gottlieb, M.S. 1992: Recombinant human erythropoietin in the treatment of anemia associated with human immunodeficiency virus (HIV) infection and zidovudine therapy. Overview of four clinical trials Annals of Internal Medicine 117(9): 739-748
Karpatkin, S.; Nardi, M.A. 1988: Immunologic thrombocytopenic purpura in human immunodeficiency virus--seropositive patients with hemophilia. Comparison with patients with classic autoimmune thrombocytopenic purpura, homosexuals with thrombocytopenia, and narcotic addicts with thrombocytopenia Journal of Laboratory and Clinical Medicine 111(4): 441-448
Postic, B.; Horvath, J.A.; Talwani, R. 2003: Antiviral treatment of human immunodeficiency virus infection: update for 2003 Journal of the South Carolina Medical Association 99(6): 148-153
Evans, B.A.; Mccormack, S.M.; Bond, R.A.; Macrae, K.D.; Thorp, R.W. 1988: Human immunodeficiency virus infection, hepatitis B virus infection, and sexual behaviour of women attending a genitourinary medicine clinic British Medical Journal 296(6620): 473-475
Rigaud, M.; Leibovitz, E.; Quee, C.S.; Kaul, A.; Nardi, M.; Pollack, H.; Lawrence, R.; DiJohn, D.; Krasinski, K.; Karpatkin, M. 1992: Thrombocytopenia in children infected with human immunodeficiency virus: long-term follow-up and therapeutic considerations Journal of Acquired Immune Deficiency Syndromes 5(5): 450-455
Cathebras, P.; Vohito, J.A.; Tamalet, C.; Yete, M.L.; Lagarde, R.; Vohito, M.D.; Ramiara, J.P.; Mbolidi, C.D.; Nama, J.; Ngbali, J.; Siopathis, M.R. 1988: Tuberculose et infection par le virus de l'immunodéficience humaine en République Centrafricaine - Tuberculosis and infection by the human immunodeficiency virus in central African Republic Medecine Tropicale 48(4): 401-407
Dercole, C.; Cravello, L.; Sperandeo, D.; Bretelle, F.; Piechon, L.; Boubli, L.; Blanc, B. 1996: Infection par le virus de l'immunodéficience humaine chez la femme enceinte : aspects généraux - Human immunodeficiency virus infection during pregnancy : generalities la Presse Medicale (1983) 25(2): 77-80
Del Olmo, J.A.; Añón, C.; Llovet, F.; Serra, M.A.; Wassel, A.; Rodrigo, J.M. 1995: Comparative study of the prevalence of hepatitis B virus infection and human immunodeficiency virus type 1 infection in the prison population between 1985 and 1992 Gastroenterologia y Hepatologia 18(8): 405-409
Erikstrup, C.; Kallestrup, P.; Zinyama-Gutsire, R.B.L.; Gomo, E.; van Dam, G.J.; Deelder, Aé.M.; Butterworth, A.E.; Pedersen, B.Klarlund.; Ostrowski, S.R.; Gerstoft, J.; Ullum, H. 2008: Schistosomiasis and infection with human immunodeficiency virus 1 in rural Zimbabwe: systemic inflammation during co-infection and after treatment for schistosomiasis American Journal of Tropical Medicine and Hygiene 79(3): 331-337